Oncostatin M causes eotaxin-1 release from airway smooth muscle: Synergy with IL-4 and IL-13

Débora S. Faffe, Lesley Flynt, Matthew Mellema, Paul E. Moore, Eric S. Silverman, Venkat Subramaniam, Matthew R. Jones, Joseph P. Mizgerd, Timothy Whitehead, Amy Imrich, Reynold A. Panettieri, Stephanie A. Shore

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Background: Eotaxin is implicated in asthmatic eosinophilia. Oncostatin M (OSM) causes eotaxin release from fibroblasts. Objective: We sought to examine the effects and mechanism of action of OSM and other IL-6 family cytokines on eotaxin release from human airway smooth muscle cells. Methods: Eotaxin 1 release was measured by means of ELISA. Western blotting was used to examine mitogen-activated protein kinase and signal transducer and activator of transcription 3 (STAT-3) phosphorylation. Eotaxin promoter activity was analyzed in cells transfected with wild-type STAT-3, a mutant form of STAT-3 that cannot be phosphorylated, and a constitutively active form of STAT-3. The mRNA and protein expression of IL-4Rα, the signaling receptor for IL-4 and IL-13, was evaluated by means of real-time PCR and flow cytometry, respectively. Results: OSM increased eotaxin 1 release and augmented IL-4- or IL-13-induced eotaxin release, whereas other IL-6 family cytokines did not. OSM caused a greater increase in STAT-3 phosphorylation and STAT-3-mediated gene transcription than other IL-6 family cytokines. OSM increased eotaxin promoter activity and augmented IL-13- and IL-4-induced increases in promoter activity. The constitutively active form of STAT-3 increased eotaxin promoter activity, whereas the mutant form of STAT-3 that cannot be phosphorylated significantly reduced eotaxin promoter activity induced by OSM or IL-4 plus OSM. OSM increased IL-4Rα mRNA and protein levels. Conclusions: OSM induces eotaxin 1 expression in human airway smooth muscle cells by a mechanism involving STAT-3. OSM synergizes with IL-13 and IL-4 to increase eotaxin 1 expression, possibly as a result of effects on IL-4Rα expression.

Original languageEnglish (US)
Pages (from-to)514-520
Number of pages7
JournalJournal of Allergy and Clinical Immunology
Volume115
Issue number3
DOIs
StatePublished - Mar 2005
Externally publishedYes

Fingerprint

Chemokine CCL11
Oncostatin M
Interleukin-13
STAT3 Transcription Factor
Interleukin-4
Smooth Muscle
Interleukin-6
Cytokines
Smooth Muscle Myocytes
Phosphorylation
Interleukin-4 Receptors
Messenger RNA
Eosinophilia
Mitogen-Activated Protein Kinases
Real-Time Polymerase Chain Reaction
Flow Cytometry
Proteins

Keywords

  • c-Jun N-terminal kinase
  • Extracellular signal-regulated kinase
  • IL-4Rα
  • Monocyte chemoattractant protein 1
  • Signal transducer and activator of transcription 3
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Faffe, D. S., Flynt, L., Mellema, M., Moore, P. E., Silverman, E. S., Subramaniam, V., ... Shore, S. A. (2005). Oncostatin M causes eotaxin-1 release from airway smooth muscle: Synergy with IL-4 and IL-13. Journal of Allergy and Clinical Immunology, 115(3), 514-520. https://doi.org/10.1016/j.jaci.2004.11.033

Oncostatin M causes eotaxin-1 release from airway smooth muscle : Synergy with IL-4 and IL-13. / Faffe, Débora S.; Flynt, Lesley; Mellema, Matthew; Moore, Paul E.; Silverman, Eric S.; Subramaniam, Venkat; Jones, Matthew R.; Mizgerd, Joseph P.; Whitehead, Timothy; Imrich, Amy; Panettieri, Reynold A.; Shore, Stephanie A.

In: Journal of Allergy and Clinical Immunology, Vol. 115, No. 3, 03.2005, p. 514-520.

Research output: Contribution to journalArticle

Faffe, DS, Flynt, L, Mellema, M, Moore, PE, Silverman, ES, Subramaniam, V, Jones, MR, Mizgerd, JP, Whitehead, T, Imrich, A, Panettieri, RA & Shore, SA 2005, 'Oncostatin M causes eotaxin-1 release from airway smooth muscle: Synergy with IL-4 and IL-13', Journal of Allergy and Clinical Immunology, vol. 115, no. 3, pp. 514-520. https://doi.org/10.1016/j.jaci.2004.11.033
Faffe, Débora S. ; Flynt, Lesley ; Mellema, Matthew ; Moore, Paul E. ; Silverman, Eric S. ; Subramaniam, Venkat ; Jones, Matthew R. ; Mizgerd, Joseph P. ; Whitehead, Timothy ; Imrich, Amy ; Panettieri, Reynold A. ; Shore, Stephanie A. / Oncostatin M causes eotaxin-1 release from airway smooth muscle : Synergy with IL-4 and IL-13. In: Journal of Allergy and Clinical Immunology. 2005 ; Vol. 115, No. 3. pp. 514-520.
@article{0399a01c0b7a4865ad6d644c02ced780,
title = "Oncostatin M causes eotaxin-1 release from airway smooth muscle: Synergy with IL-4 and IL-13",
abstract = "Background: Eotaxin is implicated in asthmatic eosinophilia. Oncostatin M (OSM) causes eotaxin release from fibroblasts. Objective: We sought to examine the effects and mechanism of action of OSM and other IL-6 family cytokines on eotaxin release from human airway smooth muscle cells. Methods: Eotaxin 1 release was measured by means of ELISA. Western blotting was used to examine mitogen-activated protein kinase and signal transducer and activator of transcription 3 (STAT-3) phosphorylation. Eotaxin promoter activity was analyzed in cells transfected with wild-type STAT-3, a mutant form of STAT-3 that cannot be phosphorylated, and a constitutively active form of STAT-3. The mRNA and protein expression of IL-4Rα, the signaling receptor for IL-4 and IL-13, was evaluated by means of real-time PCR and flow cytometry, respectively. Results: OSM increased eotaxin 1 release and augmented IL-4- or IL-13-induced eotaxin release, whereas other IL-6 family cytokines did not. OSM caused a greater increase in STAT-3 phosphorylation and STAT-3-mediated gene transcription than other IL-6 family cytokines. OSM increased eotaxin promoter activity and augmented IL-13- and IL-4-induced increases in promoter activity. The constitutively active form of STAT-3 increased eotaxin promoter activity, whereas the mutant form of STAT-3 that cannot be phosphorylated significantly reduced eotaxin promoter activity induced by OSM or IL-4 plus OSM. OSM increased IL-4Rα mRNA and protein levels. Conclusions: OSM induces eotaxin 1 expression in human airway smooth muscle cells by a mechanism involving STAT-3. OSM synergizes with IL-13 and IL-4 to increase eotaxin 1 expression, possibly as a result of effects on IL-4Rα expression.",
keywords = "c-Jun N-terminal kinase, Extracellular signal-regulated kinase, IL-4Rα, Monocyte chemoattractant protein 1, Signal transducer and activator of transcription 3, Vascular endothelial growth factor",
author = "Faffe, {D{\'e}bora S.} and Lesley Flynt and Matthew Mellema and Moore, {Paul E.} and Silverman, {Eric S.} and Venkat Subramaniam and Jones, {Matthew R.} and Mizgerd, {Joseph P.} and Timothy Whitehead and Amy Imrich and Panettieri, {Reynold A.} and Shore, {Stephanie A.}",
year = "2005",
month = "3",
doi = "10.1016/j.jaci.2004.11.033",
language = "English (US)",
volume = "115",
pages = "514--520",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Oncostatin M causes eotaxin-1 release from airway smooth muscle

T2 - Synergy with IL-4 and IL-13

AU - Faffe, Débora S.

AU - Flynt, Lesley

AU - Mellema, Matthew

AU - Moore, Paul E.

AU - Silverman, Eric S.

AU - Subramaniam, Venkat

AU - Jones, Matthew R.

AU - Mizgerd, Joseph P.

AU - Whitehead, Timothy

AU - Imrich, Amy

AU - Panettieri, Reynold A.

AU - Shore, Stephanie A.

PY - 2005/3

Y1 - 2005/3

N2 - Background: Eotaxin is implicated in asthmatic eosinophilia. Oncostatin M (OSM) causes eotaxin release from fibroblasts. Objective: We sought to examine the effects and mechanism of action of OSM and other IL-6 family cytokines on eotaxin release from human airway smooth muscle cells. Methods: Eotaxin 1 release was measured by means of ELISA. Western blotting was used to examine mitogen-activated protein kinase and signal transducer and activator of transcription 3 (STAT-3) phosphorylation. Eotaxin promoter activity was analyzed in cells transfected with wild-type STAT-3, a mutant form of STAT-3 that cannot be phosphorylated, and a constitutively active form of STAT-3. The mRNA and protein expression of IL-4Rα, the signaling receptor for IL-4 and IL-13, was evaluated by means of real-time PCR and flow cytometry, respectively. Results: OSM increased eotaxin 1 release and augmented IL-4- or IL-13-induced eotaxin release, whereas other IL-6 family cytokines did not. OSM caused a greater increase in STAT-3 phosphorylation and STAT-3-mediated gene transcription than other IL-6 family cytokines. OSM increased eotaxin promoter activity and augmented IL-13- and IL-4-induced increases in promoter activity. The constitutively active form of STAT-3 increased eotaxin promoter activity, whereas the mutant form of STAT-3 that cannot be phosphorylated significantly reduced eotaxin promoter activity induced by OSM or IL-4 plus OSM. OSM increased IL-4Rα mRNA and protein levels. Conclusions: OSM induces eotaxin 1 expression in human airway smooth muscle cells by a mechanism involving STAT-3. OSM synergizes with IL-13 and IL-4 to increase eotaxin 1 expression, possibly as a result of effects on IL-4Rα expression.

AB - Background: Eotaxin is implicated in asthmatic eosinophilia. Oncostatin M (OSM) causes eotaxin release from fibroblasts. Objective: We sought to examine the effects and mechanism of action of OSM and other IL-6 family cytokines on eotaxin release from human airway smooth muscle cells. Methods: Eotaxin 1 release was measured by means of ELISA. Western blotting was used to examine mitogen-activated protein kinase and signal transducer and activator of transcription 3 (STAT-3) phosphorylation. Eotaxin promoter activity was analyzed in cells transfected with wild-type STAT-3, a mutant form of STAT-3 that cannot be phosphorylated, and a constitutively active form of STAT-3. The mRNA and protein expression of IL-4Rα, the signaling receptor for IL-4 and IL-13, was evaluated by means of real-time PCR and flow cytometry, respectively. Results: OSM increased eotaxin 1 release and augmented IL-4- or IL-13-induced eotaxin release, whereas other IL-6 family cytokines did not. OSM caused a greater increase in STAT-3 phosphorylation and STAT-3-mediated gene transcription than other IL-6 family cytokines. OSM increased eotaxin promoter activity and augmented IL-13- and IL-4-induced increases in promoter activity. The constitutively active form of STAT-3 increased eotaxin promoter activity, whereas the mutant form of STAT-3 that cannot be phosphorylated significantly reduced eotaxin promoter activity induced by OSM or IL-4 plus OSM. OSM increased IL-4Rα mRNA and protein levels. Conclusions: OSM induces eotaxin 1 expression in human airway smooth muscle cells by a mechanism involving STAT-3. OSM synergizes with IL-13 and IL-4 to increase eotaxin 1 expression, possibly as a result of effects on IL-4Rα expression.

KW - c-Jun N-terminal kinase

KW - Extracellular signal-regulated kinase

KW - IL-4Rα

KW - Monocyte chemoattractant protein 1

KW - Signal transducer and activator of transcription 3

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=20044363972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20044363972&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2004.11.033

DO - 10.1016/j.jaci.2004.11.033

M3 - Article

C2 - 15753898

AN - SCOPUS:20044363972

VL - 115

SP - 514

EP - 520

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 3

ER -